News Overview

Gross NPA for the quarter increased to 2.42% from 2.71% the previous quarter, while net NPA fell to 0.33% from 0.36% in March.

Alembic Pharmaceuticals has got the final approval from USFDA for Dabigatran Etexilate Capsules, 110 mg.

No new positions can be taken in F&O contracts of stocks under the ban period.

The majority of natural gas produced domestically is currently controlled by two price regimes.

Brainbees Solutions raised a total of ₹4,194 crore through the IPO, comprising a fresh issue of ₹1,666 crore and an offer-for-sale of 5.4 crore equity shares

The closing stocks are expected to be significantly greater than they were a year ago, up 39.2% for August and 57% for September.

According to reports, BPCL is examining the land offer and may shortly decide on a single site.

LIC continues to grow faster on new business premiums, but it is the private insurers dominating policies sold

The dollar was trading at 147.17 yen, after briefly reaching a one-week high of 148.23 overnight before profit-taking set in.

A good way to participate in the banking story in India is through a passive fund, and that is evident in longer term returns